KEYCORP NEW
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Capital
Our capital management objective is to maintain capital levels consistent with our risk appetite and of a sufficient amount to operate under a wide range of economic conditions. Our current capital levels position us well to execute against our capital priorities including supporting organic growth and paying dividends.
The following sections discuss certain ways we have deployed our capital. For further information, see the Consolidated Statements of Changes in Equity and Note 24 (“Shareholders' Equity”).
(a)Common Share repurchases were suspended during the second quarter of 2020 in response to the COVID-19 pandemic and resumed in the first quarter of 2021.
Dividends
Consistent with our capital plans, the Board declared a quarterly dividend of $.205 per Common Share for each of the four quarters of 2024. These quarterly dividend payments brought our annual dividend to $.82 per Common Share for 2024.
Common Shares outstanding
Our Common Shares are traded on the NYSE under the symbol KEY with 27,154 holders of record at December 31, 2024. Our book value per Common Share was $14.21 based on 1.1 billion shares outstanding at
December 31, 2024, compared to $13.02 based on 936.6 million shares outstanding at December 31, 2023. At December 31, 2024, our tangible book value per Common Share was $11.70, compared to $10.02 at December 31, 2023.
Figure 21 shows activities that caused the change in our outstanding Common Shares over the past two years.
Figure 21. Changes in Common Shares Outstanding
| 2024 Quarters | ||||||
|---|---|---|---|---|---|---|
| In thousands | 2024 | Fourth | Third | Second | First | 2023 |
| Shares outstanding at beginning of period | 936,564 | 991,251 | 943,200 | 942,776 | 936,564 | 933,325 |
| Open market share repurchases | — | — | — | — | — | (2,550) |
| Shares issued under employee compensation plans (net of cancellations and returns) | 7,351 | 493 | 222 | 424 | 6,212 | 5,789 |
| Shares issued under Scotiabank investment agreement | 162,871 | 115,042 | 47,829 | — | — | — |
| Shares outstanding at end of period | 1,106,786 | 1,106,786 | 991,251 | 943,200 | 942,776 | 936,564 |
During 2024, Common Shares outstanding increased by 170.2 million shares, primarily driven by issuances under the Scotiabank investment agreement. For more information on share activity, see Note 24 (“Shareholders' Equity”).
At December 31, 2024, we had 149.9 million treasury shares, compared to 320.1 million treasury shares at December 31, 2023. The decrease in treasury shares during the year was primarily attributable to the issuance of 162.9 million shares to Scotiabank in connection with the strategic minority investment. Going forward, we expect to reissue treasury shares as needed in connection with stock-based compensation awards and for other corporate purposes.
Capital adequacy
Capital adequacy is an important indicator of financial stability and performance. All of our capital ratios remained in excess of regulatory requirements at December 31, 2024. Our capital and liquidity levels are intended to position us to weather an adverse operating environment while continuing to serve our clients’ needs, as well as to meet the Regulatory Capital Rules described in the “Supervision and regulation” section of Item 1 of this report. Our shareholders’ equity to assets ratio was 9.7% at December 31, 2024, compared to 7.8% at December 31, 2023. Our tangible common equity to tangible assets ratio was 7.0% at December 31, 2024, compared to 5.1% at December 31, 2023. The minimum capital and leverage ratios under the Regulatory Capital Rules together with the estimated ratios of KeyCorp at December 31, 2024, calculated on a fully phased-in basis, are set forth under the heading “Basel III” in the “Supervision and Regulation” section in Item 1 of this report.
Figure 22 represents the details of our regulatory capital positions at December 31, 2024, and December 31, 2023, under the Regulatory Capital Rules. Information regarding the regulatory capital ratios of KeyCorp’s banking subsidiaries is presented in Note 24 (“Shareholders' Equity”).
Figure 22. Capital Components and Risk-Weighted Assets
| December 31, Dollars in millions · 2024 · 2023 | ||||
|---|---|---|---|---|
| Key shareholders’ equity (GAAP) | $18,176 | $14,637 | ||
| Less: | Preferred Stock (a) | 2,446 | 2,446 | |
| Add: | CECL phase-in (b) | 59 | 118 | |
| Common Equity Tier 1 capital before adjustments and deductions | 15,789 | 12,309 | ||
| Less: | Goodwill, net of deferred taxes | 2,574 | 2,594 | |
| Intangible assets, net of deferred taxes | 24 | 49 | ||
| Deferred tax assets | 172 | 1 | ||
| Net unrealized gains (losses) on available-for-sale securities, net of deferred taxes | (2,729) | (4,296) | ||
| Accumulated gains (losses) on cash flow hedges, net of deferred taxes | (438) | (656) | ||
| Amounts in AOCI attributed to pension and postretirement benefit costs, net of deferred taxes | (303) | (277) | ||
| Total Common Equity Tier 1 capital | 16,489 | 14,894 | ||
| TIER 1 CAPITAL | ||||
| Common Equity Tier 1 | 16,489 | 14,894 | ||
| Additional Tier 1 capital instruments and related surplus | 2,445 | 2,446 | ||
| Less: | Deductions | — | — | |
| Total Tier 1 capital | 18,934 | 17,340 | ||
| TIER 2 CAPITAL | ||||
| Tier 2 capital instruments and related surplus | 1,767 | 2,020 | ||
| Allowance for losses on loans and liability for losses on lending-related commitments (c) | 1,635 | 1,668 | ||
| Less: | Deductions | — | — | |
| Total Tier 2 capital | 3,402 | 3,688 | ||
| Total risk-based capital | $22,336 | $21,028 | ||
| RISK-WEIGHTED ASSETS | ||||
| Risk-weighted assets on balance sheet | $105,047 | $115,861 | ||
| Risk-weighted off-balance sheet exposure | 31,883 | 31,555 | ||
| Market risk-equivalent assets | 1,366 | 1,159 | ||
| Gross risk-weighted assets | 138,296 | 148,575 | ||
| Less: | Excess allowance for loan and lease losses | — | — | |
| Net risk-weighted assets | $138,296 | $148,575 | ||
| AVERAGE QUARTERLY TOTAL ASSETS | $188,855 | $191,948 | ||
| CAPITAL RATIOS | ||||
| Tier 1 risk-based capital | 13.69% | 11.67% | ||
| Total risk-based capital | 16.15 | 14.15 | ||
| Leverage (d) | 10.03 | 9.03 | ||
| Common Equity Tier 1 | 11.92 | 10.02 | ||
(a)Net of capital surplus.
(b)Amount reflects our decision to adopt the CECL transitional provision.
(c)The ALLL included in Tier 2 capital is limited by regulation to 1.25% of the institution’s standardized total risk-weighted assets (excluding its standardized market risk-weighted assets). The ALLL includes $13 million and $16 million of allowance classified as “discontinued assets” on the balance sheet at December 31, 2024, and December 31, 2023, respectively.
(d)This ratio is Tier 1 capital divided by average quarterly total assets as defined by the Federal Reserve less: (i) goodwill, (ii) the disallowed intangible and deferred tax assets, and (iii) other deductions from assets for leverage capital purposes.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.